Clinical Trial Update: Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis [Phase 2]

View source ↗

Summary

A Phase 2 trial of inhaled iloprost for adults with pulmonary hypertension associated with idiopathic pulmonary fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis
• Pulmonary Hypertension

Drugs mentioned

• Iloprost (iloprost)

Snippet

Sponsor: Actelion | Conditions: Pulmonary Fibrosis, Pulmonary Hypertension | Phase 2 | Status: COMPLETED